Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00743574 · ClinicalTrials.gov registry record · NA
Health Benefits of Vitamin D and Calcium in Women With PCOS (Polycystic Ovarian Syndrome)
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT00743574 is a NA study that has completed, run by Yale University. The registered enrollment target is 36 participants.
The verdict
NCT00743574, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
The investigators conducted a prospective un-blinded pilot study of Vitamin D plus Calcium (Ca) supplementation in overweight (BMI \> 27) premenopausal women diagnosed with Polycystic Ovarian Syndrome (PCOS), as defined by the Rotterdam Criteria, 2003, and who were deficient in vitamin D as reflected by serum 25-hydroxy (25-OH) vitamin D (serum levels \< 20 ng/mL).
Interventions
- DIETARY_SUPPLEMENT Vitamin D3 (Cholecalciferol)
- DIETARY_SUPPLEMENT Vitamin D2 (Ergocalciferol)
- DRUG Medroxyprogesterone (Provera)
- DIETARY_SUPPLEMENT Elemental Calcium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2008-08 |
| Est. Completion | 2013-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00743574
The ClinicalTrials.gov registry entry for NCT00743574 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Vitamin D3 (Cholecalciferol) is the first listed.
NCT00743574 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00743574 about?
NCT00743574 is a clinical study titled "Health Benefits of Vitamin D and Calcium in Women With PCOS (Polycystic Ovarian Syndrome)". The investigators conducted a prospective un-blinded pilot study of Vitamin D plus Calcium (Ca) supplementation in overweight (BMI \> 27) premenopausal women diagnosed with Polycystic Ovarian Syndrome (PCOS), as defined by the Rotterdam Criteria, 2003, and who were deficient in vitamin D as reflecte...
What is the current status of trial NCT00743574?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2008-08. Estimated completion is 2013-02.
What interventions are being tested in trial NCT00743574?
The interventions under investigation include: Vitamin D3 (Cholecalciferol) (DIETARY_SUPPLEMENT), Vitamin D2 (Ergocalciferol) (DIETARY_SUPPLEMENT), Medroxyprogesterone (Provera) (DRUG), Elemental Calcium (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00743574?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.